🔎 Trials Near Me

Hjem › Multippel sklerose › Arizona

Kliniske studier for Multippel sklerose i Arizona

6 studier for Multippel sklerose søker deltakere på steder i Arizona.

Byer i Arizona

Offisiell studietekst (engelsk)

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

  • Perseverance Research Center,LLC, Scottsdale
RekruttererFase 2
Alder 18 til 70 · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06782490

A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy

  • Clinical Endpoints, LLC, Scottsdale
RekruttererFase 4
Alder 18 til 65 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07609719

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

  • TG Therapeutics Investigational Trial Site, Gilbert
  • TG Therapeutics Investigational Trial Site, Phoenix
  • TG Therapeutics Investigational Trial Site, Scottsdale
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT06433752

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • University of Arizona, Tucson
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07002034

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

  • Center for Neurology and Spine - Phoenix - East Bell Road- Site Number : 8400195, Phoenix
  • Perseverance Research Center- Site Number : 8400138, Scottsdale
RekruttererFase 3
Alder 18 til 60 · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07325292

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  • Ctr for Neurology and Spine, Phoenix
  • AZ Integrated Neuro and Spine, Phoenix
  • Center for Neurosciences, Tucson
RekruttererFase 3
Alder 18 til 65 · Alle kjønn · Oppdatert 29. jul. 2026 · NCT07225504

Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.